Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Make way for MiniMed! Medtronic's diabetes division has filed the necessary paperwork to go public. The company hopes to be traded on Nasdaq under the symbol MMED.
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
Nashville-based HCA Healthcare operates in 21 states, and mass numbers of patients in all but one of them may have had personal information offered for sale as a list on the deep web.
With a bit fewer than 7 million residents, Massachusetts ranks a middling 16th in population among the states. However, when it comes to internet searches for terms associated with emerging technologies per 100,000 residents, the Bay State is No. 1.
It was only last fall that Open AI’s ChatGPT thrust generative AI into the public psyche. Since then, many future-looking surveys have shown unease and trepidation competing hard for mindshare against hope and excitement.
The senior statistician purchased short-term stock options, including some that expired the next day, after allegedly being made aware of Paxlovid’s success in clinical trials ahead of a public announcement.